
| Salt Composition: | Cefixime (200mg) + Clavulanic Acid (125mg) |
| Manufacturer: | Medius Biotech |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Cefyus CV 200mg/125mg Tablet is a combination medicine prescribed to treat various types of bacterial infections by preventing the growth and spread of microorganisms. Cefyus CV 200mg/125mg Tablet is a prescription medicine used to treat bacterial infections. It can be taken with or without food but should be taken at a fixed time for better efficacy. Do not exceed the recommended dose as it may have harmful effects. Complete the course of treatment even if you feel better to avoid resistance. Common side effects include nausea, vomiting, diarrhea, and indigestion. Consult your doctor if side effects worsen or if you experience any allergic reactions. Pregnant or breastfeeding women should consult their doctor before taking this medicine. Avoid alcohol as it can cause excessive drowsiness. Adequate rest, a healthy diet, and plenty of water are recommended for faster recovery.
Cefyus CV 200mg/125mg Tablet is a combination of Cefixime and Clavulanic Acid. Cefixime is an antibiotic that prevents the formation of the bacterial protective covering essential for bacterial survival. Clavulanic Acid is a beta-lactamase inhibitor that reduces resistance and enhances the activity of Cefixime against bacteria.
Take this medicine in the dose and duration as advised by your doctor. Swallow it whole without chewing, crushing, or breaking it. It can be taken with or without food but is better taken at a fixed time.
Alcohol
Caution is advised when consuming alcohol with Cefyus CV 200mg/125mg Tablet. Please consult your doctor.
Breastfeed
Cefyus CV 200mg/125mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy
Cefyus CV 200mg/125mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.